Maravai Lifesciences

MRVINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.937 B

$7.46 +4.04%

Close of 22 Sept 2026

Revenue

$185.7M

#2310 by revenue

Earnings

-$130.8M

Loss-making

Shares outstanding

147,215,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#113PERRIGOPRGO$1.99B
#114ZymeworksZYME$1.96B
#115Maravai LifesciencesMRVI$1.94B
#116GH ResearchGHRS$1.91B
#117SepternaSEPN$1.88B

What if Maravai Lifesciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$116,430.65

Per share 15,607× higher

Bitcoin $1.74T

$6,707.09

Per share 899× higher

Nvidia $5.52T

$21,241.15

Per share 2,847× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Maravai Lifesciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.